Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 208-015-6 | CAS number: 505-65-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: OECD 403, GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1300 (Acute inhalation toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Commission Regulation (EC) No 440/2008
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Experimental Toxicology and Ecology, BASF SE
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- 1,3-dioxepane
- EC Number:
- 208-015-6
- EC Name:
- 1,3-dioxepane
- Cas Number:
- 505-65-7
- Molecular formula:
- C5H10O2
- IUPAC Name:
- 1,3-dioxepane
- Details on test material:
- Name of test substance: Butandiolformal
Test substance No.: 09/0372-2
Batch No.: BU 16
Purity: 99.63 %
Homogeneity: homogeneous
Physical state/appearance: liquid/colorless, clear
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Test animals:
Age at day 0: males approx. 8 weeks, females approx. 10 weeks
Supplier: Harlan Nederland, Kreuzelweg 53, NL-5961 NM Horst
Acclimatization for at least 5 days before exposure.
Body weight at day 0: males 206.78 +/-8.55, females 228.26 +/-3.18
HOUSING AND DIET
The animals were housed in air-conditioned rooms.
Room temperature: 20-24°C
Relative humidity: 30 – 70% for relative humidity.
15 air changes per hour.
Day / night rhythm: 12 h/12 h
Number of animals per cage: Single housing or up to 5 animals
Diet: Kliba-Labordiät (Maus / Ratte Haltung “GLP”), Provimi Kliba SA, Kaiseraugst, Basel, Switzerland, ad libitum
Drinking water: tap water ad libitum
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- nose/head only
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Head-nose inhalation system INA 20 (glass-steel construction, BASF SE)
- Exposure chamber volume: 55l
- Method of holding animals in test chamber: the animals were restrained in glass tubes and their snouts projected into the inhalation system.
- Source and rate of air: compressed air, supply air flow 1.5 m³/h, exhaust air flow: 1.35 m³/h. An air change of about 27 times per hour was calculated by dividing the supply air flows by the volume of the inhalation system.
- System of generating vapor: Vaporisers (glasses with thermostat) Piston metering pump KP 2000 (Desaga/Sarstedt). The vapor was generated by supplying amounts of the test substance to the heated vaporizer by means of the pump. The vapors that developed were taken up by the supply air and passed into the exposure system. The generator temperature was 50°C.
TEST ATMOSPHERE
Nominal concentration was calculated from the amount of test substance dosed and the supply air flow.
- Brief description of analytical method used: quantitative determination of the vapor concentration by gas chromatography.
- Sampling method: Air sampler GS 312 (DESAGA) was used. A sampling probe (diameter: 4 mm) and 3 fritted glass flasks connected in series and filled with sorption solvent (methanol) were used.
- Samples taken from breathing zone: yes (immediately adjacent to the animals' noses at a separate spare port)
- Sampling flow: 1 L/min
- Sampling velocity: 1.25 m/s
- Sampling frequency: 4 samples at about hourly intervals
- Sample volume: 1 L - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 20.8 mg/l
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- To evaluate morphological changes of respiratory tract, a satellite group (3 male rats) was exposed to the test substance simultaneously with the main group animals. One male animal was exposed to fresh air and served as control animal for histological examination. The satellite animals (3 test animal + 1 control) were sacrificed on post exposure study day 2.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 20.8 mg/L air (analytical)
- Exp. duration:
- 4 h
- Mortality:
- No mortality occurred.
- Clinical signs:
- other: No clinical signs of toxicity were observed in the control animal. In the test substance exposure group accelerated respiration (slight to moderate), unconsciousness, hyperexcitability, poor general state, unsteady gait, eye encrusted red and piloerectio
- Body weight:
- The mean body weights of the animals decreased during the first few post exposure observation days and increased from study day 7 onward.
- Gross pathology:
- No gross pathological abnormalities were detected during the necropsy in the main group animals at the termination of the post exposure observation period.
- Other findings:
- Pathology:
a minimal increase in the absolute (9.5%) and relative (14.4%) lung weights in animals from the satellite group was considered to be non-adverse, since no histopathological correlate was observed.
No histopathologic findings were observed in the respiratory organs, except in one male where minimal granulocytic infiltration in the larynx at level II was noted but was regarded as non-adverse.
Concentration measurements:
Nominal concentration 25.5 mg/L
mean analytical concentration 20.8 mg/L +/-1.0
Applicant's summary and conclusion
- Conclusions:
- Following acute inhalation exposure the test subsance is practically non toxic according to EU standards.
- Executive summary:
At the limit dose of 20.8 mg/l the test substance did not result in mortality. Furthermore no signs of systemic toxicity were observed and in a satellite group no indications of respiratory irritation were detected histopathologically.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
